“…this stands up to scientific rigor and is worthy of further exploration.”
This company is approaching psychedelic mushroom research literally from the ground up.
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
“I believe one person can produce enough 5-MeO-DMT to supply everyone that would ever want it.”